首页> 外文期刊>International Journal of Hypertension >Management of Hypertension among Patients with Coronary Heart Disease
【24h】

Management of Hypertension among Patients with Coronary Heart Disease

机译:冠心病患者的高血压管理

获取原文
获取外文期刊封面目录资料

摘要

Evidence suggests that coronary heart disease (CHD) is the most common outcome of hypertension. Hypertension accelerates the development of atherosclerosis, and sustained elevation of blood pressure (BP) can destabilize vascular lesions and precipitate acute coronary events. Hypertension can cause myocardial ischemia in the absence of CHD. These cardiovascular risks attributed to hypertension can be reduced by optimal BP control. Although several antihypertensive agents exist, the choice of agent and the appropriate target BP for patients with CHD remain controversial. In this succinct paper, we examine the evidence and the mechanisms for the linkage between hypertension and CHD and we discuss the treatment options and the goals of therapy that are consistent with the report of the seventh Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) and American Heart Association scientific statement. We anticipate changes in the recommendations of the forthcoming JNC 8.
机译:有证据表明,冠心病(CHD)是高血压最常见的结局。高血压会加速动脉粥样硬化的发展,持续升高的血压(BP)会破坏血管病变的稳定性并引发急性冠脉事件。在没有冠心病的情况下,高血压可引起心肌缺血。最佳血压控制可以降低归因于高血压的这些心血管风险。尽管存在几种降压药,但对于CHD患者,其选择药物和合适的目标血压仍存在争议。在这篇简洁的论文中,我们研究了高血压和冠心病之间联系的证据和机制,并讨论了与第七届预防,检测,评估全国联合委员会的报告相一致的治疗方案和治疗目标,和治疗高血压(JNC 7)和美国心脏协会的科学声明。我们预计即将发布的JNC 8的建议将有所变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号